The effects of the injection of a large amount of A^-methylnicotinamide (MNA)(500 mg per kg body weight) on the ratio of A^-methyM-pyridone-S-carboxamide (4-py) to A^-methyl^-pyridone-Scarboxamide (2-py) excretion, and the activities of 2-py and 4-py forming MNAoxidases were investigated in rats. The injected MNAwas excreted very rapidly into the urine; 46 % of the dose was excreted from 0~3hr post-injection, 15% from 3~6hr, 6% from 6~9hr and 1.5% from 9~12hr. The ratio of 4-py to 2-py also decreased rapidly; the ratio being about 0.6, 0.4, 0.4 and 0.6 from 0~3hr, 3~6hr, 6~9hr and 9~12hr post-injection, respectively. This ratio then recovered rapidly; being about 2, 5.5, 8.5 and 9.7 from 12~24hr, 24~48hr, 48~72hr and 72~96hr post-injection, respectively. The normal range of 4-py to 2-py excretion ratio is 8~14. So, this ratio returned to a normal level by day 3 post-injection. The rats were killed 5 hr after the MNAinjection. At this time (the lowest ratio was observed around this time), the activities of 2-py and 4-py forming MNAoxidases in the injected group were 59 % and ll %of the normal levels, respectively. Therefore, it was found that the decreased ratio of 4-py to 2-py excretion with the MNA injection was mainly due to the higher inhibition of the 4-py forming MNAoxidase than of the 2-py forming MNAoxidase by the MNA injection.
Stanulovic and Chaykin,1* and Shibata and Matsuo2) have reported that the ratio of N1-methyl-4-pyridone-3-carboxamide (4-py) to A^1-methy-2-pyridone-5-carboxamide (2-py) excretion decreased whena large amountof A^-methylnicotinamide (MNA) was injected into rats; the range of this ratio in rats fed a normal diet is 8~14, but it was 0.7 on day 1 post-injection with MNA.Namely, when a large amount of MNAwas injected into rats, the synthesis of 2-py from MNAwas higher than that of 4-py from MNA.So, we considered that the higher increase in 2-py synthesis than in 4-py synthesis following the injection ofa large amount of MNAis due to the contribution of xanthine oxidase, because it is reported that the milk3) and hog liver4)
xanthine oxidases are capable of oxidizing MNA to 2-py in vitro, with a high MNA concentration. However, it was found that this might be not the main reason from the results obtained here. In this study, the course of the change in the 
Materials and Methods
Chemicals. MNA-C1was purchased from Tokyo Kasei Kogyo Co., Ltd. 2-Py and 4-py were synthesized by the methods of Pullman and Colowick,5' and Shibata et al.,6) respectively. All other chemicals used were of the highest purity available from commercial sources.
Animals and diets. Twentyrats of the Wistar strain (five week old) were purchased from Clea Japan Inc. The rate were immediately placed individually in rat metabolic cages (CT-10; from Clea Japan Inc.) and fed a 20% casein diet (Table  I) MNA-C1 perkg body weight (164.9±9.3g, mean±S.D., n= 10) dissolved in 1 ml of sterilized saline was intrapertoneally injected at 09: 00hr on the 1lth day. As acontrol, 
Effect of the injection of a large amount of
MNAon the urinary excretion of its metabolites, 2-py and 4-py Table II shows the time courses of the urinary excretion of MNA,2-py and 4-py following the injection of a large amount of MNAinto rats (500mg/kg body weight). The injected MNA was excreted very rapidly; e.g., 46% of the dose was excreted from 0-3hr post-injection, 15% from 3-6hr and 6% from 6~9hr. On day 1, 70% of the dose was excreted into the urine, and on day 2, 0.7% of the dose was excreted. On day 3, the urinary excretion of MNAwas still slightly higher in the injected group than in the control group.
On day 4, the urinary excretion did not differ between the two groups. 3-hr and then decreased gradually in the order of0-3, 3-6, 6-9 and 9-12hr. Theurinary excretion of 2-py was higher than the urinary excretion of 4-py at 12 hr post-injection.
Course of the change in the ratio of4-py to 2-py excretion following the injection of a large amount of MNA Figure 1 shows the course of the change in the ratio of 4-py to 2-py excretion following the injection of a large amount of MNA. The lowest ratio was observed at 0~3, 3~6 and 6~9hr post-injection, and then it increased gradually and had returned to a normal value by day 3.
Inhibition ofMNAoxidase by a large amount of
MNA
The rats were killed 5hr after the MNA injection. Their livers were removed, and the activities of 2-py and 4-py MNAoxidases were measured. The results are shown in Table III. 2-Py forming MNAoxidase activity decreased by a half and 4-py forming MNAoxidase activity by 1/10 with the MNAinjection. In the preliminary experiment, 2-py and 4-py forming MNA oxidase activities were measured 24hr after the MNAinjection.
The values for enon was due to the contribution of xanthine oxidase, since xanthine oxidase can only act as a catalyst when there is a high MNAconcentration in the liver.6/7) However, the results obtained here indicated that this may not be the main reason; with the injection of a pharmacological dose of MNA, the activities of 2-py and 4-py forming MNAoxidases were inhibited and the inhibition was much higher for the 4-py forming MNAoxidase than for the 2-py forming MNAoxidase. In our previous study,2) the ratio of 4-py to 2-py excretion was found to be greatly decreased on day 1 post-injection. Therefore, in this experiment, urinesamplesfor0-3, 3-6, 6-9, 9-12 and 12-24hr after the injection were collected. [8] [9] [10] [11] [12] [13] [14] . Therefore, this ratio decreased very rapidly. The lowest value for this ratio was observed at around 3-9 hr, so rats were killed 5 hr after the injection to investigate the effect of a pharmacological dose of MNAon the 2-py and 4-py forming MNAoxidase activities.
It was found that both the 2-py and 4-py forming MNA oxidase activities were inhibited by the injected MNAand the inhibition was much higher for the 4-py forming MNAoxidase than for the 2-py forming MNAoxidase. The activity ratio of the 4-py forming MNA oxidase (269 nmol/hr/g liver) to the 2-py forming MNAoxidase (422nmol/hr/g liver) was 0.64, and the ratio of 4-py to 2-py excretion from 0-9hr was around 0.5. Therefore, the change in the ratio of the enzymeactivities was almost coincident with the change in the ratio of 4-py to 2-py excretion. The absolute excretion of 2-py and 4-py was much higher in the injected group than in the control group, even when the activities of the 2-py and 4-py forming MNAoxidases had been greatly decreased by a pharmacological dose of MNA. This is due to the large amount of the substrate, MNA.Another factor concerned with the decrease in the ratio of4-py to 2-py excretion was that the synthesis of2-py from MNA was much higher than that of 4-py from MNA, when the MNA level in the assay reaction mixture was elevated. Thus, the ratio of 4-py to 2-py excretion decreased when excess MNA was injected.
This inhibition was reversed when the excretion of MNAin the injected group had returned to a normal level.
However, MNAitself did not inhibit the MNA oxidase in vitro. Namely, MNAoxidase was not subject to substrate inhibition by MNA. 
